NCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown
Clinical Trials
4 trialsNCT05288127 2022-03-21
Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature
University of Malaya
Phase 2 Unknown
NCT04824937 2021-04-01
Telaglenastat + Talazoparib In Prostate Cancer
Massachusetts General Hospital
Phase 2 Unknown
NCT04755868 2021-02-16
Talazoparib Maintenance Therapy in Triple-negative Breast Cancer
Yonsei University
Phase 2 Unknown